Medial prefrontal cortex endocannabinoid system modulates baroreflex activity through CB1 receptors
Contribuinte(s) |
UNIVERSIDADE DE SÃO PAULO |
---|---|
Data(s) |
01/11/2013
01/11/2013
2012
|
Resumo |
Ferreira-Junior NC, Fedoce AG, Alves FHF, Correa FMA, Resstel LBM. Medial prefrontal cortex endocannabinoid system modulates baroreflex activity through CB1 receptors. Am J Physiol Regul Integr Comp Physiol 302: R876-R885, 2012. First published December 28, 2011; doi: 10.1152/ajpregu.00330.2011.-Neural reflex mechanisms, such as the baroreflex, are involved in the regulation of cardiovascular system activity. Previous results from our group (Resstel LB, Correa FM. Medial prefrontal cortex NMDA receptors and nitric oxide modulate the parasympathetic component of the baroreflex. Eur J Neurosci 23: 481-488, 2006) have shown that glutamatergic synapses in the ventral portion of the medial prefrontal cortex (vMPFC) modulate baroreflex activity. Moreover, glutamatergic neurotransmission in the vMPFC can be modulated by the endocannabinoids system (eCBs), particularly the endocannabinoid anandamide, through presynaptic CB1 receptor activation. Therefore, in the present study, we investigated eCBs receptors that are present in the vMPFC, and more specifically whether CB1 receptors modulate baroreflex activity. We found that bilateral microinjection of the CB1 receptor antagonist AM251 (100 or 300 pmol/200 nl) into the vMPFC increased baroreflex activity in unanesthetized rats. Moreover, bilateral microinjection of either the anandamide transporter inhibitor AM404 (100 pmol/200 nl) or the inhibitor of the enzyme fatty acid amide hydrolase that degrades anandamide, URB597 (100 pmol/200 nl), into the MPFC decreased baroreflex activity. Finally, pretreatment of the vMPFC with an ineffective dose of AM251 (10 pmol/200 nl) was able to block baroreflex effects of both AM404 and URB597. Taken together, our results support the view that the eCBs in the vMPFC is involved in the modulation of baroreflex activity through the activation of CB1 receptors, which modulate local glutamate release. Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/07332-3, 2009/03187-9] Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [305996/2008-8, 470042/2009-5] Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da FMRP-USP (FAEPA) Fundacao de Apoio ao Ensino, Pesquisa e Assistencia (FAEPA) do Hospital das Clinicas da FMRPUSP |
Identificador |
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, BETHESDA, v. 302, n. 7, supl. 1, Part 6, pp. R876-R885, APR, 2012 0363-6119 http://www.producao.usp.br/handle/BDPI/37604 10.1152/ajpregu.00330.2011 |
Idioma(s) |
eng |
Publicador |
AMER PHYSIOLOGICAL SOC BETHESDA |
Relação |
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY |
Direitos |
restrictedAccess Copyright AMER PHYSIOLOGICAL SOC |
Palavras-Chave | #ANANDAMIDE #AUTONOMIC SYSTEM #CANNABINOIDS #INFRALIMBIC CORTEX #PRELIMBIC CORTEX #CONDITIONED EMOTIONAL RESPONSES #CENTRAL-NERVOUS-SYSTEM #CANNABINOID RECEPTOR #PARASYMPATHETIC COMPONENT #UNANESTHETIZED RATS #FRONTAL-CORTEX #PRELIMBIC CORTEX #ANANDAMIDE #LESIONS #BRAIN #PHYSIOLOGY |
Tipo |
article original article publishedVersion |